Patient-derived organoids reveal strain-specific efficacy of engineered bacteria in colorectal cancer
Katherine O’Connor, Deniz Erkok, Josephine A. Wright, Paige Steppe, Kate R. Barratt, Laura Vrbanac, Dan L. Worthley, Susan L. Woods, Jeff Hasty Communications Medicine
· Springer Nature
· 2026-11-18
· DOI: 10.1038/s43856-026-01992-x
Abstract
Communications Medicine, Published online: 18 November 2026; doi:10.1038/s43856-026-01992-x ED Summary: O’Connor et al. use a patient-derived organoid co-culture platform to evaluate engineered bacterial therapies for colorectal cancer and capture strain- and patient-specific responses. Both bacteria preferentially colonise tumours, but attenuated Salmonella shows stronger colonisation and biological effects than E. coli Nissle.
Katherine O’Connor, Deniz Erkok, Josephine A. Wright, Paige Steppe, Kate R. Barratt, Laura Vrbanac et al. Patient-derived organoids reveal strain-specific efficacy of engineered bacteria in colorectal cancer. // Communications Medicine. – 2026. – DOI: 10.1038/s43856-026-01992-x. – URL: https://www.nature.com/articles/s43856-026-01992-x
Katherine O’Connor, Deniz Erkok, Josephine A. Wright, Paige Steppe, Kate R. Barratt, Laura Vrbanac, Dan L. Worthley, Susan L. Woods, & Jeff Hasty (2026). Patient-derived organoids reveal strain-specific efficacy of engineered bacteria in colorectal cancer. Communications Medicine. https://doi.org/10.1038/s43856-026-01992-x
Katherine O’Connor, et al. “Patient-derived organoids reveal strain-specific efficacy of engineered bacteria in colorectal cancer.” Communications Medicine, 2026. doi:10.1038/s43856-026-01992-x.
@article{OConnor2026,
title = {Patient-derived organoids reveal strain-specific efficacy of engineered bacteria in colorectal cancer},
author = {O’Connor, Katherine and Erkok, Deniz and Wright, Josephine A. and Steppe, Paige and Barratt, Kate R. and Vrbanac, Laura and Worthley, Dan L. and Woods, Susan L. and Hasty, Jeff},
journal = {Communications Medicine},
year = {2026},
doi = {10.1038/s43856-026-01992-x},
url = {https://www.nature.com/articles/s43856-026-01992-x}
}
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02013-7 The authors identify the mitochondrial RNA methyltransferase, NSUN4 as a potential therapeutic target in intrahepatic cholangiocarcinoma, with...
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02009-3 People with type 2 diabetes can have too much sugar in their blood stream, which can lead to health problems. Metformin is a common medication...
Communications Medicine, Published online: 17 November 2026; doi:10.1038/s43856-026-02012-8 Macrophage Slfn4 attenuates colonic inflammation and tumorigenesis through Rac1-dependent phagocytosis and oxidative burst
Communications Medicine, Published online: 16 November 2026; doi:10.1038/s43856-026-01727-y Ozawa et al. simulated the impact of misinformation in Canada on individuals delaying and refusing vaccination during the COVID-19 pandemic....
Communications Medicine, Published online: 14 November 2026; doi:10.1038/s43856-026-01987-8 Garel et al. explore the influence of the personality trait absorption in the MUSIK trial which administered 181 doses of ketamine, with either...